Meta plans to test new subscriptions that give people access to exclusive features on its apps, the company told TechCrunch on Monday. The tech giant said the new subscriptions will unlock more ...
Déjà vu all over again. That describes the status of the lengthy tug of war between Attorney General Andrea Campbell and state Auditor Diana DiZoglio over the latter’s authority to inspect the inner ...
Reports from last year hinted that OpenAI was planning to show ads in ChatGPT. Turns out, those reports were accurate. In an announcement from earlier today, the company has confirmed that OpenAI will ...
“I’m looking for help to make a decision. My confusion is over a few things, but primarily about my employment. When I ask older relatives how they got through the times when they were dissatisfied ...
The House Judiciary Committee on Wednesday released a full transcript and video of former special counsel Jack Smith's closed-door deposition before the Republican-led panel earlier this month. The ...
Today’s Wordle answer is so out of left field that it seems to have sparked a resurgence in online conversation. The New York Times puzzle is a daily word guessing game that launched in 2021, and ...
Aehr Test Systems (NASDAQ:AEHR) Q3 2025 Earnings Call Transcript April 8, 2025 Operator: Greetings. Welcome to the Aehr Test Systems Fiscal 2025 Third Quarter Financial Results Call. At this time, all ...
Aehr Test Systems (NASDAQ:AEHR) Q4 2025 Earnings Call Transcript July 8, 2025 Aehr Test Systems beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.015. Operator: Greetings.
Victoria Fernández carried out the study detailed in this article as part of a project financed with funding from the MCINN/AEI and European Union NextGenerationEU/PRTR, which ended in September 2025.
As Trump lurches wildly in all directions on “affordability,” an economist explains the real reasons his approval on the economy is imploding—and why it will likely get worse right through the ...
Freenome is taking itself public via a special purpose acquisition company, also known as a SPAC deal, to help raise funds in preparation for the planned 2026 launch of its blood-based screening tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results